To explore the potential tumorigenic activity of the AHR-HDAC8 axis, an inducible expression system overexpressing AHR, a constitutively activated AHR mutant (CA1) [10], and HDAC8 was tested in two HCC cell lines (Hep 3B and SK Hep1). Here, HDAC8 is linked to hepatocellular carcinoma.